What is Dovato?
Dovato is a prescription medication that combines two active ingredients, dolutegravir and lamivudine, into a single daily tablet. It is a complete antiretroviral regimen used for the treatment of Human Immunodeficiency Virus 1 (HIV-1) infection. HIV is a virus that attacks the body’s immune system. Dovato helps control the virus but is not a cure for HIV. It is designed for adults who are either starting HIV-1 treatment for the first time or are replacing their current HIV-1 medications.
How does Dovato work?
Dovato works by using its two active ingredients to stop the HIV virus from replicating in the body. Dolutegravir is an integrase strand transfer inhibitor (INSTI). It blocks an enzyme called integrase, which the virus needs to insert its genetic material into human immune cells (CD4 cells). Lamivudine is a nucleoside analog reverse transcriptase inhibitor (NRTI). It blocks reverse transcriptase, another enzyme the virus uses to make copies of itself. By disrupting this process, Dovato effectively reduces the amount of HIV in the blood (the viral load).
Who is Dovato for?
Dovato is intended for adults and adolescents aged 12 and older who weigh at least 40 kg (88 lbs) with HIV-1 infection. It is prescribed for those who have not previously taken antiretroviral therapy. It can also be used to replace the current antiretroviral regimen for individuals who are virologically suppressed. This means their viral load is consistently low on a stable treatment plan. Your doctor will determine if Dovato is the right choice based on your medical history and current health status.
Dosage and administration
Dovato is typically prescribed as one tablet taken orally once each day. The tablet can be taken with or without food, offering flexibility for daily schedules. It is important to take Dovato at the same time every day to maintain stable levels of the medicine in your blood. Be sure to follow your doctor’s instructions precisely. Certain other medicines, like calcium or iron supplements and some antacids, can interfere with how Dovato is absorbed. It should be taken at least two hours before or six hours after these products.
Side effects
Dovato may cause some side effects, although not everyone will experience them. The most common side effects are generally mild and can include headaches, diarrhea, nausea, and difficulty sleeping. Some people may also feel dizzy or tired. More serious side effects are rare but can happen. These include severe allergic reactions, liver problems, and worsening depression or mood changes. If you have a history of depression, watch for any new or worsening symptoms. Contact your healthcare provider immediately if you experience a skin rash, yellowing skin or eyes, or thoughts of self-harm.
Why buy from IsraelPharm?
IsraelPharm provides a reliable and affordable way to access your essential medications like Dovato. We are committed to making treatment more accessible by offering competitive pricing on brand-name drugs sourced from regulated international pharmacies. Our streamlined online ordering process is simple, secure, and convenient. A licensed pharmacist reviews every prescription to ensure accuracy and safety. With discreet packaging and direct shipping to your door, IsraelPharm is your trusted partner for managing your health effectively and affordably.
Most people taking Dovato do not experience serious side effects. However, like any medication, it has potential risks. Consult your doctor for a full list of side effects.
Common side effects may include:
- Headache
- Nausea or Diarrhea
- Difficulty sleeping (insomnia)
- Fatigue or lack of energy
- Anxiety
Less common but serious side effects can include:
- Allergic reactions (hypersensitivity), such as rash and fever.
- Liver problems (hepatotoxicity), especially in patients with Hepatitis B or C.
- Worsening depression or suicidal thoughts.
Seek immediate medical help if you experience signs of an allergic reaction, liver problems (dark urine, yellow skin), or thoughts of self-harm.
Dovato is a prescription medication indicated for the treatment of HIV-1 infection in adults and adolescents (12 years and older weighing at least 40kg) who are:
- Starting antiretroviral therapy for the first time (treatment-naïve).
- Replacing their current antiretroviral regimen while virologically suppressed (having a stable, low viral load).